Baxter
BAX
£26.00
Share price
1.24%
Change (1 day)
-21.62%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
Baxter (BAX) - Net assets
Net assets on the balance sheet as of December 2024 : £5.43 Billion
According to Baxter's latest financial reports the company has £5.43 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Baxter - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $£5.59 B | -15.79% |
| 2023-12-31 | $£6.64 B | 36.41% |
| 2022-12-31 | $£4.87 B | -27.89% |
| 2021-12-31 | $£6.75 B | 5.55% |
| 2020-12-31 | $£6.40 B | 6.1% |
| 2019-12-31 | $£6.03 B | -2.63% |
| 2018-12-31 | $£6.19 B | -8.13% |
| 2017-12-31 | $£6.74 B | 0.52% |
| 2016-12-31 | $£6.71 B | 12.17% |
| 2015-12-31 | $£5.98 B | 14.19% |
| 2014-12-31 | $£5.23 B | 1.83% |
| 2013-12-31 | $£5.14 B | 19.16% |
| 2012-12-31 | $£4.31 B | -1.72% |
| 2011-12-31 | $£4.39 B | -0.21% |
| 2010-12-31 | $£4.40 B | -3.99% |
| 2009-12-31 | $£4.58 B | 7.89% |
| 2008-12-31 | $£4.25 B | 22.08% |
| 2007-12-31 | $£3.48 B | 8.72% |
| 2006-12-31 | $£3.20 B | 28.44% |
| 2005-12-31 | $£2.49 B | 29.18% |
| 2004-12-31 | $£1.92 B | 5.44% |
| 2003-12-31 | $£1.83 B | -0.15% |
| 2002-12-31 | $£1.83 B | -29.26% |
| 2001-12-31 | $£2.59 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | -£2.27 Billion | -141.59% | 🇺🇸 USA |
 | £15.96 B | 193.76% | 🇺🇸 USA |
 | £17.02 B | 213.25% | 🇺🇸 USA |
 | £19.50 B | 258.83% | 🇺🇸 USA |
 | £0.28 B | -94.82% | 🇺🇸 USA |
 | £38.43 B | 607.18% | 🇺🇸 USA |
 | £0.43 B | -91.95% | 🇺🇸 USA |
 | £37.69 B | 593.56% | 🇮🇪 Ireland |
 | £1.52 B | -72.02% | 🇺🇸 USA |